Human neutralizing antibodies elicited by SARS-CoV-2 infection

Ju, Bin, Zhang, Qi, Ge, Jiwan, Wang, Ruoke, Sun, Jing, Ge, Xiangyang, Yu, Jiazhen, Shan, Sisi +16 more·2020·Nature

DOI 10.1038/s41586-020-2380-z

Cited by (1,008)

Items 501–600 of 1,008

Principles of SARS-CoV-2 glycosylation
Himanshi Chawla, Elisa Fadda, Max Crispin · 2022 · Current Opinion in Structural Biology
SARS-CoV-2 multi-variant rapid detector based on graphene transistor functionalized with an engineered dimeric ACE2 receptor
Alice Romagnoli, Mattia D’Agostino, Eleonora Pavoni, Chiara Ardiccioni, Stefano Motta, Paolo Crippa, Giorgio Biagetti, Valentina Notarstefano, Jesmina Rexha, Nunzio Perta et al. · 2022 · Nano Today
A third dose of inactivated vaccine augments the potency, breadth, and duration of anamnestic responses against SARS-CoV-2
Kang Wang, Yunlong Cao, Yunjiao Zhou, Jiajing Wu, Zijing Jia, Yaling Hu, Ayijiang Yisimayi, Wangjun Fu, Lei Wang, Pan Liu et al. · 2021 · medRxiv
Development of potency, breadth and resilience to viral escape mutations in SARS-CoV-2 neutralizing antibodies
Muecksch, Frauke, Weisblum, Yiska, Barnes, Christopher O., Schmidt, Fabian, Schaefer-Babajew, Dennis, Lorenzi, Julio C C, Flyak, Andrew I, DeLaitsch, Andrew T, Huey-Tubman, Kathryn E, Hou, Shurong et al. · 2021
What could explain the late emergence of COVID-19 in Africa?
Rym Lalaoui, Sofiane Bakour, Didier Raoult, Pierre Verger, C. Sokhna, Christian Albert Devaux, Bruno Pradines, Jean‐Marc Rolain · 2020 · New Microbes and New Infections
Dynamic Characteristic Analysis of Antibodies in Patients With COVID-19: A 13-Month Study
Danrong Shi, Tian-Hao Weng, Jie Wu, Chunyan Dai, Rui Luo, Keda Chen, Miaojin Zhu, Xiangyun Lu, Linfang Cheng, Qiuqiang Chen et al. · 2021 · Frontiers in Immunology
SARS-CoV-2 Virus−Host Interaction: Currently Available Structures and Implications of Variant Emergence on Infectivity and Immune Response
Luís Queirós-Reis, Priscilla Gomes da Silva, José Gonçalves, Andrea Brancale, Marcella Bassetto, João R. Mesquita · 2021 · International Journal of Molecular Sciences
A non-ACE2 competing human single-domain antibody confers broad neutralization against SARS-CoV-2 and circulating variants
Zhen-Lin Yang, Yulu Wang, Yu-jia Jin, Yuan-Fei Zhu, Yan-Ling Wu, Cheng Li, Yu Kong, Wen-Ping Song, Xiaolong Tian, Wuqiang Zhan et al. · 2021 · Signal Transduction and Targeted Therapy
Leveraging deep learning to improve vaccine design
Andrew P. Hederman, Margaret E. Ackerman · 2023 · Trends in Immunology
Functional comparison of SARS-CoV-2 with closely related pangolin and bat coronaviruses
Jianhui Nie, Qianqian Li, Li Zhang, Yang Cao, Yue Zhang, Tao Li, Jiajing Wu, Shuo Liu, Mengyi Zhang, Chenyan Zhao et al. · 2021 · Cell Discovery
Cross-Neutralization of Emerging SARS-CoV-2 Variants of Concern by Antibodies Targeting Distinct Epitopes on Spike
Siriruk Changrob, Yanbin Fu, Jenna J. Guthmiller, Peter Halfmann, Lei Li, Christopher T. Stamper, Haley L. Dugan, Molly Accola, William Rehrauer, Nai-Ying Zheng et al. · 2021 · mBio
A second functional furin site in the SARS-CoV-2 spike protein
Yue Zhang, Li Zhang, Jiajing Wu, Yuanling Yu, Shuo Liu, Tao Li, Qianqian Li, Ruxia Ding, Haixin Wang, Jianhui Nie et al. · 2021 · Emerging Microbes & Infections
Immuno-epidemiology and pathophysiology of coronavirus disease 2019 (COVID-19)
Omalla Allan Olwenyi, Shetty Ravi Dyavar, Arpan Acharya, Anthony T. Podany, Courtney Vail Fletcher, Caroline L. Ng, St Patrick Reid, Siddappa N. Byrareddy · 2020 · Journal of Molecular Medicine
Passive Immunotherapy Against SARS-CoV-2: From Plasma-Based Therapy to Single Potent Antibodies in the Race to Stay Ahead of the Variants
William R. Strohl, Zhiqiang Ku, Zhiqiang An, Stephen F. Carroll, Bruce A. Keyt, Lila M. Strohl · 2022 · BioDrugs
Reshaping cell line development and CMC strategy for fast responses to pandemic outbreak
Zheng Zhang, Ji Chen, Jung-hua Wang, Qiao Gao, Zhu-Jun Ma, Shu-Rong Xu, Li Zhang, J. Cai, Wei-Chang Zhou · 2020 · Biotechnology progress (Print)
Characteristics of Anti-SARS-CoV-2 Antibodies in Recovered COVID-19 Subjects
Angela Huynh, Donald M. Arnold, James W. Smith, Jane C. Moore, Ali Zhang, Zain Chagla, Bart J. Harvey, Hannah D. Stacey, Jann Catherine Ang, Rumi Clare et al. · 2021 · Viruses
N439K Variant in Spike Protein Alter the Infection Efficiency and Antigenicity of SARS-CoV-2 Based on Molecular Dynamics Simulation
Wenyang Zhou, Chang Xu, Pingping Wang, Meng Luo, Zhaochun Xu, Rui Cheng, Xiyun Jin, Yu Guo, Guangfu Xue, Liran Juan et al. · 2021 · Frontiers in Cell and Developmental Biology
Magnetofluidic immuno-PCR for point-of-care COVID-19 serological testing
Pengfei Zhang, Liben Chen, Jiumei Hu, Alexander Y. Trick, Fan‐En Chen, Kuangwen Hsieh, Yang Zhao, Branch Coleman, Kate L. Kruczynski, Thomas R. Pisanic et al. · 2021 · Biosensors and Bioelectronics
S19W, T27W, and N330Y mutations in ACE2 enhance SARS-CoV-2 S-RBD binding toward both wild-type and antibody-resistant viruses and its molecular basis
Fei Ye, Xi Lin, Zimin Chen, Fanli Yang, Sheng Lin, Jing Yang, Hua Chen, Honglu Sun, Lingling Wang, Ao Wen et al. · 2021 · Signal Transduction and Targeted Therapy
Surface charge changes in spike RBD mutations of SARS-CoV-2 and its variant strains alter the virus evasiveness via HSPGs: A review and mechanistic hypothesis
Zhongyun Zhang, Juan Zhang, Jiqiu Wang · 2022 · Frontiers in Public Health
Pathogenesis, Symptomatology, and Transmission of SARS-CoV-2 through Analysis of Viral Genomics and Structure
Halie M. Rando, Adam L. MacLean, Alexandra J. Lee, Ronan Lordan, Sandipan Ray, Vikas Bansal, Ashwin N. Skelly, Elizabeth Sell, John J. Dziak, Lamonica Shinholster et al. · 2021 · mSystems
Structural basis for SARS-CoV-2 neutralizing antibodies with novel binding epitopes
D. Fu, Guang-Shun Zhang, Yuhui Wang, Zheng Zhang, Heng-Rui Hu, S. Shěn, Jun Wu, Bo Li, Xin Li, Yao-Hui Fang et al. · 2021 · PLoS Biology
Regional and temporal coordinated mutation patterns in SARS-CoV-2 spike protein revealed by a clustering and network analysis
Surendra S. Negi, Catherine H. Schein, Werner A. Braun · 2022 · Scientific Reports
Aspects of Phage-Based Vaccines for Protein and Epitope Immunization
Marco Palma · 2023 · Vaccines
Rabies virus-based COVID-19 vaccine CORAVAX™ induces high levels of neutralizing antibodies against SARS-CoV-2
Drishya Kurup, Christoph Wirblich, Holly R. Ramage, Matthias J. Schnell · 2020 · npj Vaccines
Germline immunoglobulin genes: Disease susceptibility genes hidden in plain sight?
Andrew M. Collins, Gur Yaari, Adrian J. Shepherd, William Lees, Corey T. Watson · 2020 · Current Opinion in Systems Biology
SARS-CoV-2 Cysteine-like Protease Antibodies Can Be Detected in Serum and Saliva of COVID-19–Seropositive Individuals
Pedro Martínez‐Fleta, Arántzazu Alfranca, Isidoro González‐Álvaro, José M. Casasnovas, Daniel Fernández‐Soto, Gloria Esteso, Yaiza Cáceres‐Martell, Sofía R. Gardeta, Celia López‐Sanz, Salomé Prat et al. · 2020 · The Journal of Immunology
Recent Insights into Emerging Coronavirus: SARS-CoV-2
Zifang Shang, Siew Yin Chan, William J. Liu, Peng Li, Wei Huang · 2020 · ACS Infectious Diseases
SARS-CoV-2: Immune Response Elicited by Infection and Development of Vaccines and Treatments
Gisela Canedo-Marroquín, Farides Saavedra, Catalina A. Andrade, Roslye V. Berríos-Rojas, Linmar Rodríguez‐Guilarte, María Cecilia Opazo, Claudia A. Riedel, Alexis M. Kalergis · 2020 · Frontiers in Immunology
A Highly Automated Mobile Laboratory for On-site Molecular Diagnostics in the COVID-19 Pandemic
Wanli Xing, Jiadao Wang, Zhao Chao, Han Wang, Liang Bai, Liangbin Pan, Hang Li, Huili Wang, Zhi Zhang, Ying Lu et al. · 2021 · Clinical Chemistry
Treatment and prevention strategies for the COVID 19 pandemic: A review of immunotherapeutic approaches for neutralizing SARS-CoV-2
Pravas Kumar Baral, Jiang Yin, Michael N.G. James · 2021 · International Journal of Biological Macromolecules
A pair of noncompeting neutralizing human monoclonal antibodies protecting from disease in a SARS‐CoV‐2 infection model
Antonia Sophia Peter, Edith A. Roth, Sebastian R. Schulz, Kirsten Fraedrich, Tobit D. Steinmetz, Dominik Damm, Manuela Hauke, Elie Richel, Sandra M. Mueller-Schmucker, Katharina Marie Habenicht et al. · 2021 · European Journal of Immunology
IgG3 and IgM Identified as Key to SARS-CoV-2 Neutralization in Convalescent Plasma Pools
Christina Kober, Sandro Manni, Svenja Wolff, Thomas W. Barnes, Shatanik Mukherjee, Thomas Vogel, Lea Hoenig, Vogel Peter, Aaron Hahn, Michaela Gerlach et al. · 2022 · PLoS ONE
Rapid Protection from COVID-19 in Nonhuman Primates Vaccinated Intramuscularly but Not Intranasally with a Single Dose of a Vesicular Stomatitis Virus-Based Vaccine
Wakako Furuyama, Kyle Shifflett, Amanda N. Pinski, Amanda J. Griffin, Friederike Feldmann, Atsushi Okumura, Tylisha Gourdine, Allen Jankeel, Jamie Lovaglio, Patrick W. Hanley et al. · 2022 · mBio
Parallel profiling of antigenicity alteration and immune escape of SARS-CoV-2 Omicron and other variants
Cong Sun, Yinfeng Kang, Yuan-Tao Liu, Xiang‐Wei Kong, Hui-Qin Xu, Dan Xiong, Chu Xie, Yihao Liu, Sui Peng, Guo‐Kai Feng et al. · 2022 · Signal Transduction and Targeted Therapy
Nanoparticle and virus-like particle vaccine approaches against SARS-CoV-2
Chulwoo Kim, Jae-Deog Kim, Sang‐Uk Seo · 2022 · The Journal of Microbiology
Molecular adaptations during viral epidemics
Nash D. Rochman, Yuri I. Wolf, Eugene V. Koonin · 2022 · EMBO Reports
Structure-based neutralizing mechanisms for SARS-CoV-2 antibodies
Qingrui Huang, Xiaonan Han, Jinghua Yan · 2022 · Emerging Microbes & Infections
Allosteric Cross-Talk among Spike’s Receptor-Binding Domain Mutations of the SARS-CoV-2 South African Variant Triggers an Effective Hijacking of Human Cell Receptor
Angelo Spinello, Andrea Saltalamacchia, Jure Borišek, Alessandra Magistrato · 2021 · The Journal of Physical Chemistry Letters
Long-Term Analysis of Antibodies Elicited by Sputnik V in Tucuman, Argentina
Rossana Elena Chahla, Rodrigo Hernán Tomas‐Grau, Silvia I. Cazorla, Diego Ploper, Esteban Vera Pingitore, Mónica Aguilar López, Patricia Aznar, María Elena Alcorta, Eva María del Mar Vélez, Agustín Stagnetto et al. · 2021 · The Lancet Regional Health - Americas
BL02U1: the relocated macromolecular crystallography beamline at the Shanghai Synchrotron Radiation Facility
Ke Liu, Huan Zhou, Qin Lan Xu, Huating Kong, Kunhao Zhang, Weiwei Wang, Min-Jun Li, Zhijun Wang, Qiang-Yan Pan, Xing-Ya Wang et al. · 2023 · Nuclear Science and Techniques
The E3 ligase TRIM22 restricts SARS-CoV-2 replication by promoting proteasomal degradation of NSP8
Lujie Fan, Yuzheng Zhou, Xiafei Wei, Wei Feng, Huimin Guo, Yunfei Li, Xiang Gao, Jian Zhou, Yanling Wen, Yezi Wu et al. · 2024 · mBio
ADE and hyperinflammation in SARS-CoV2 infection- comparison with dengue hemorrhagic fever and feline infectious peritonitis
Maryse Cloutier, Madhuparna Nandi, Awais Ullah Ihsan, Hugues Allard‐Chamard, Subburaj Ilangumaran, Sheela Ramanathan · 2020 · Cytokine
Review of COVID-19 Antibody Therapies
Jiahui Chen, Kaifu Gao, Rui Wang, Duc Duy Nguyen, Guo‐Wei Wei · 2020 · Annual Review of Biophysics
Therapeutic antibodies, targeting the SARS-CoV-2 spike N-terminal domain, protect lethally infected K18-hACE2 mice
Tal Noy-Porat, Adva Mechaly, Yinon Levy, Efi Makdasi, Ron Alcalay, David Gur, Moshe Aftalion, Reut Falach, Shani Leviatan Ben‐Arye, Shirley Lazar et al. · 2021 · iScience
Egg yolk immunoglobulin (IgY) targeting SARS-CoV-2 S1 as potential virus entry blocker
Lirong Bao, Cheng Zhang, Jinglu Lyu, Ping Yi, Xin Shen, Boyu Tang, Hang Zhao, Biao Ren, Yu Kuang, Linlin Zhou et al. · 2021 · Journal of Applied Microbiology
Probing Affinity, Avidity, Anticooperativity, and Competition in Antibody and Receptor Binding to the SARS-CoV-2 Spike by Single Particle Mass Analyses
Victor C. Yin, Szu-Hsueh Lai, T. Caniels, P. Brouwer, Mitch Brinkkemper, Y. Aldon, Hejun Liu, M. Yuan, Ian A. Wilson, R. Sanders et al. · 2021 · ACS Central Science
Performance evaluation of four surrogate Virus Neutralization Tests (sVNTs) in comparison to the in vivo gold standard test
Massimo Pieri, Maria Giaele Infantino, Mariangela Manfredi, Marzia Nuccetelli, Valentina Grossi, Barbara Lari, Flaminia Tomassetti, Serena Sarubbi, Edda Russo, Amedeo Amedei et al. · 2022 · Frontiers in Bioscience-Landmark
Vaccine-elicited murine antibody WS6 neutralizes diverse beta-coronaviruses by recognizing a helical stem supersite of vulnerability
Wei Shi, Lingshu Wang, Tongqing Zhou, Mallika Sastry, Eun Sung Yang, Yi Zhang, Man Chen, Xuejun Chen, Misook Choe, Adrian Creanga et al. · 2022 · Structure
Severe Acute Respiratory Syndrome Coronavirus 2: From Gene Structure to Pathogenic Mechanisms and Potential Therapy
Jun Wu, Xiaohui Yuan, Bing Wang, Rui Gu, Wei Li, Xuemei Xiang, Lijun Tang, Hongyu Sun · 2020 · Frontiers in Microbiology
Newcastle Disease Virus-Like Particles Displaying Prefusion-Stabilized SARS-CoV-2 Spikes Elicit Potent Neutralizing Responses
Yongping Yang, Wei Shi, Olubukola M. Abiona, Alexandra F. Nazzari, Adam S. Olia, Li Ou, Emily Phung, Tyler Stephens, Yaroslav Tsybovsky, Raffaello Verardi et al. · 2021 · Vaccines
Evaluation of a Pseudovirus Neutralization Assay for SARS-CoV-2 and Correlation with Live Virus-Based Micro Neutralization Assay
Ahmed M. Tolah, Sayed Sartaj Sohrab, Khaled M. Tolah, Ahmed M. Hassan, Sherif Aly El-Kafrawy, Esam I. Azhar · 2021 · Diagnostics
Monoclonal Antibodies against SARS-CoV-2: Current Scenario and Future Perspectives
Eugenia Quirós-Roldán, Silvia Amadasi, Isabella Zanella, Melania Degli Antoni, Samuele Storti, Giorgio Tiecco, Francesco Castelli · 2021 · Pharmaceuticals
Enhanced SARS-CoV-2 Neutralization by Secretory IgA in vitro
Zijun Wang, Julio C. C. Lorenzi, Frauke Muecksch, Shlomo Finkin, Charlotte Viant, Christian Gaebler, Melissa Cipolla, Hans-Heinrich Hoffmann, Thiago Y. Oliveira, Deena A. Oren et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
Spike-antibody responses to ChAdOx1 and BNT162b2 vaccines by demographic and clinical factors (Virus Watch study)
Madhumita Shrotri, Ellen Fragaszy, Cyril Geismar, Vincent Grigori Nguyen, Sarah Beale, Isobel Braithwaite, Thomas Byrne, Wing Lam Erica Fong, Jana Kovar, Annalan M D Navaratnam et al. · 2021 · medRxiv
Influence of treatment with neutralizing monoclonal antibodies on the SARS-CoV-2 nasopharyngeal load and quasispecies
Camille Vellas, Arnaud Del Bello, Alexa Debard, Zara Steinmeyer, Laure Tribaudeau, Noémie Ranger, Nicolas Jeanne, Guillaume Martin‐Blondel, Pierre Delobel, Nassim Kamar et al. · 2021 · Clinical Microbiology and Infection
Mechanisms of Dysregulated Humoral and Cellular Immunity by SARS-CoV-2
N. Taefehshokr, Sina Taefehshokr, B. Heit · 2020 · Pathogens
Perspective on therapeutic and diagnostic potential of camel nanobodies for coronavirus disease-19 (COVID-19)
Salma Bessalah, Samira Jebahi, Naceur Mejri, Imed Salhi, Touhami Khorchani, Mohamed Hammadi · 2021 · 3 Biotech
Impact of the N501Y substitution of SARS-CoV-2 Spike on neutralizing monoclonal antibodies targeting diverse epitopes
Lin Cheng, Shuo Song, Bing Zhou, Xiangyang Ge, Jiazhen Yu, Mingxia Zhang, Bin Ju, Zheng Zhang · 2021 · Virology Journal
The mRNA-1273 Vaccine Induces Cross-Variant Antibody Responses to SARS-CoV-2 With Distinct Profiles in Individuals With or Without Pre-Existing Immunity
Sonia Tejedor Vaquero, Leire de Campos‐Mata, José María Ramada, Pilar Díaz, Juan Navarro‐Barriuso, Clara Ribas‐Llauradó, Natalia Rodrigo Melero, Carlo Carolis, Andrea Cerutti, Ramón Gimeno et al. · 2021 · Frontiers in Immunology
Population homogeneity for the antibody response to COVID-19 BNT162b2/Comirnaty vaccine is only reached after the second dose across all adult age ranges
João Faro Viana, Marie‐Louise Bergman, Lígia Antunes Gonçalves, Nádia Duarte, Teresa Penha Coutinho, Patrícia Borges, Christian Diwo, Rute Castro, Paula Matoso, Vanessa Malheiro et al. · 2022 · Nature Communications
Self-Assembling Nanoparticle Vaccines Displaying the Receptor Binding Domain of SARS-CoV-2 Elicit Robust Protective Immune Responses in Rhesus Monkeys
Heng Li, Lei Guo, Hui-Wen Zheng, Jing Li, Xin Zhao, Jia-Qi Li, Yan Liang, Fengmei Yang, Yu-Rong Zhao, Jin-Ling Yang et al. · 2021 · Bioconjugate chemistry
A pandemic-enabled comparison of discovery platforms demonstrates a naïve antibody library can match the best immune-sourced antibodies
F. Ferrara, M. F. Erasmus, S. D'Angelo, Camila Leal-Lopes, Andre A. R. Teixeira, A. Choudhary, W. Honnen, D. Calianese, De-Li Huang, Linghang Peng et al. · 2022 · Nature Communications
DNA aptamers inhibit SARS-CoV-2 spike-protein binding to hACE2 by an RBD- independent or dependent approach
Achut Prasad Silwal, Siddhartha Kalpa Samadhi Thennakoon, Satya Prakash Arya, Rick Mason Postema, Raunak Jahan, Chien Minh Tran Phuoc, Xiaohong Tan · 2022 · Theranostics
Characterization of SARS-CoV-2 Variants B.1.617.1 (Kappa), B.1.617.2 (Delta), and B.1.618 by Cell Entry and Immune Evasion
Wenlin Ren, Xiaohui Ju, Mingli Gong, Jun Lan, Yanying Yu, Quanxin Long, Devin Kenney, Aoife Kateri O’Connell, Yu Long Zhang, Jin Zhong et al. · 2022 · mBio
Somatic hypermutation introduces bystander mutations that prepare SARS-CoV-2 antibodies for emerging variants
Michael Korenkov, Matthias Zehner, Hadas Cohen‐Dvashi, Aliza Borenstein-Katz, Lisa Kottege, Hanna Janicki, Kanika Vanshylla, Timm Weber, Henning Gruell, Manuel Koch et al. · 2023 · Immunity
COVID‐19 vaccines: Knowing the unknown
Huibin Lv, Nicholas C. Wu, Chris Ka Pun Mok · 2020 · European Journal of Immunology
2020 update on human coronaviruses: One health, one world
Xinbin Zhao, Yuecheng Ding, Jing Du, Yubo Fan · 2020 · Medicine in Novel Technology and Devices
Systemic innate and adaptive immune responses to SARS-CoV-2 as it relates to other coronaviruses
Patrick O’Connell, Yasser Ali Aldhamen · 2020 · Human Vaccines & Immunotherapeutics
Kinetics of Viral Clearance and Antibody Production Across Age Groups in Children with Severe Acute Respiratory Syndrome Coronavirus 2 Infection
Burak Bahar, Cyril Jacquot, Yunchuan Delores Mo, Roberta L. DeBiasi, Joseph M. Campos, Meghan Delaney · 2020 · The Journal of Pediatrics
Sensitivity and specificity of SARS-CoV-2 S1 subunit in COVID-19 serology assays
Ying Tian, Chaoyang Lian, Yingying Chen, Dong Wei, Xinxin Zhang, Yun Ling, Ying Wang, Leng-Siew Yeap · 2020 · Cell Discovery
A Potent SARS-CoV-2 Neutralizing Human Monoclonal Antibody That Reduces Viral Burden and Disease Severity in Syrian Hamsters
Anna Claire Fagre, John Manhard, Rachel A Adams, Miles Eckley, Shi-Jun Zhan, Juliette Lewis, Savannah M. Rocha, Catherine M. Woods, Karina Kuo, Wuxiang Liao et al. · 2020 · Frontiers in Immunology
Double lock of a potent human therapeutic monoclonal antibody against SARS-CoV-2
Ling Zhu, Yong‐Qiang Deng, Rong-Rong Zhang, Zhen Cui, Chun-Yun Sun, Changfa Fan, Xiaorui Xing, Weijin Huang, Qi Chen, Na-Na Zhang et al. · 2020 · National Science Review
A review on the immune responses against novel emerging coronavirus (SARS-CoV-2)
Ramin Lotfi, Rasoul Nasiri Kalmarzi, Seyed Askar Roghani · 2021 · Immunologic Research
Isolation of a panel of ultra-potent human antibodies neutralizing SARS-CoV-2 and viral variants of concern
A. Gorchakov, S. Kulemzin, S. Guselnikov, K. Baranov, T. N. Belovezhets, L. Mechetina, O. Volkova, A. Najakshin, N. Chikaev, A. Chikaev et al. · 2021 · Cell Discovery
Mechanism of a COVID-19 nanoparticle vaccine candidate that elicits a broadly neutralizing antibody response to SARS-CoV-2 variants
Yi-Nan Zhang, Jennifer A. Paynter, Cindy Sou, Tatiana Fourfouris, Ying Wang, Ciril Abraham, Timothy A Ngo, Yi Zhang, Lin-Ling He, Jiang Zhu · 2021 · Science Advances
Three SARS-CoV-2 antibodies provide broad and synergistic neutralization against variants of concern, including Omicron
Siling Wang, Hui Sun, Yali Zhang, Lunzhi Yuan, Yizhen Wang, Tianying Zhang, Shaojuan Wang, Jinlei Zhang, Hai Jing Yu, Hualong Xiong et al. · 2022 · Cell Reports
Broadly neutralizing antibodies to SARS-related viruses can be readily induced in rhesus macaques
Wan-ting He, M. Yuan, Sean Callaghan, Rami Musharrafieh, G. Song, Murillo Silva, N. Beutler, W. Lee, Peter Yong, J. Torres et al. · 2021 · bioRxiv
Combining Phage Display Technology with In Silico -Designed Epitope Vaccine to Elicit Robust Antibody Responses against Emerging Pathogen Tilapia Lake Virus
Yu‐Ming Gong, Xuefeng Wei, Yuying Zheng, Yang Li, Qing Cissy Yu, Pengfei Li, Bin Zhu · 2023 · Journal of Virology
Antiviral Protein–Protein Interaction Inhibitors
Violeta R. Marković, Anna Szczepańska, Łukasz Berlicki · 2024 · Journal of Medicinal Chemistry
Early experience with convalescent plasma as immunotherapy for COVID‐19 in China: Knowns and unknowns
Binzhen Chen, Rong Xia · 2020 · Vox Sanguinis
COVID-19 illness and autoimmune diseases: recent insights
Juan Li, Honghui Liu, Xiao‐Dong Yin, Chengcheng Li, Jing Wang · 2021 · Inflammation Research
A Rapid and Efficient Screening System for Neutralizing Antibodies and Its Application for SARS-CoV-2
Xiaojian Han, Yingming Wang, Shenglong Li, Chao Hu, Tingting Li, Chenjian Gu, Kai Wang, Meiying Shen, Jianwei Wang, Jie Hu et al. · 2021 · Frontiers in Immunology
Diverse immunoglobulin gene usage and convergent epitope targeting in neutralizing antibody responses to SARS-CoV-2
Xiaojuan Zhou, Fengge Ma, Jun Xie, M. Yuan, Yunqiao Li, N. Shaabani, Fang-Zhu Zhao, De-Li Huang, Nicholas C. Wu, C. D. Lee et al. · 2021 · Cell Reports
Interference of Polydatin/Resveratrol in the ACE2:Spike Recognition during COVID-19 Infection. A Focus on Their Potential Mechanism of Action through Computational and Biochemical Assays
Fulvio Perrella, Federico Coppola, Alessio Petrone, Chiara Platella, Daniela Montesarchio, Annarita Stringaro, Giampietro Ravagnan, Maria Pia Fuggetta, Nadia Rega, Domenica Musumeci · 2021 · Biomolecules
Rapid, label-free, and sensitive point-of-care testing of anti-SARS-CoV-2 IgM/IgG using all-fiber Fresnel reflection microfluidic biosensor
Wenjuan Xu, Jiayao Liu, Dan Song, Chunsheng Li, Anna Zhu, Feng Long · 2021 · Microchimica Acta
Computationally Designed ACE2 Decoy Receptor Binds SARS-CoV-2 Spike (S) Protein with Tight Nanomolar Affinity
Brandon Havranek, Kui K. Chan, Austin Wu, Erik Procko, Shahidul M. Islam · 2021 · Journal of Chemical Information and Modeling
SARS-CoV-2 Variants, RBD Mutations, Binding Affinity, and Antibody Escape
Lin Yang, Jiacheng Li, Shuai Guo, Chengyu Hou, Chenchen Liao, Liping Shi, Xiaoliang Ma, Shenda Jiang, Bing Zheng, Yi Fang et al. · 2021 · International Journal of Molecular Sciences
Nasal Spray of Neutralizing Monoclonal Antibody 35B5 Confers Potential Prophylaxis Against Severe Acute Respiratory Syndrome Coronavirus 2 Variants of Concern: A Small-Scale Clinical Trial
Yao Lin, Shuai Yue, Yang Yang, Sen Yang, Zhiwei Pan, Xiaofan Yang, Leiqiong Gao, Jing Zhou, Zhirong Li, Hu Li et al. · 2022 · Clinical Infectious Diseases
Immunity after COVID-19 Recovery and Vaccination: Similarities and Differences
Dorota Kamińska, Dominika Dęborska−Materkowska, Katarzyna Kościelska−Kasprzak, Oktawia Mazanowska, Agata Remiorz, Paweł Poznański, Magdalena Durlik, Magdalena Krajewska · 2022 · Vaccines
Limited Humoral and Specific T-Cell Responses After SARS-CoV-2 Vaccination in PWH With Poor Immune Reconstitution
Susana Benet, Oscar Blanch-Lombarte, Erola Ainsua‐Enrich, Núria Pedreño-López, Jordana Muñoz‐Basagoiti, Dàlia Raïch Regué, Daniel Perez‐Zsolt, Ruth Peña, Esther Jímenez, Maria Luisa Rodrı́guez de la Concepción et al. · 2022 · The Journal of Infectious Diseases
Antibodies targeting a quaternary site on SARS-CoV-2 spike glycoprotein prevent viral receptor engagement by conformational locking
Lihong Liu, Ryan G. Casner, Yicheng Guo, Qian Wang, Sho Iketani, Jasper Fuk‐Woo Chan, Jian Yu, Bernadeta Dadonaite, Manoj S. Nair, Hiroshi Mohri et al. · 2023 · Immunity
Selection, biophysical and structural analysis of synthetic nanobodies that effectively neutralize SARS-CoV-2
Tânia F. Custódio, Hrishikesh Das, Daniel J. Sheward, Leo Hanke, Samuel Pažický, Joanna Pieprzyk, Michèle Sorgenfrei, Martin A. Schroer, Andrey Yu. Gruzinov, Cy Michael Jeffries et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
The Loss of Bcl-6 Expressing T Follicular Helper Cells and the Absence of Germinal Centers in COVID-19
Naoki Kaneko, Hsiao-Hsuan Kuo, Julie Boucau, Jocelyn R. Farmer, Hugues Allard‐Chamard, Vinay S. Mahajan, Alicja K. Trocha, Kristina Lefteri, Matt Osborn, Julia Bals et al. · 2020 · SSRN Electronic Journal
SARS CoV-2 Delta variant exhibits enhanced infectivity and a minor decrease in neutralization sensitivity to convalescent or post-vaccination sera
A. Kuzmina, Seraj Wattad, Y. Khalaila, A. Ottolenghi, B. Rosental, Stanislav Engel, Elli Rosenberg, R. Taube · 2021 · iScience
A High-Throughput Assay for Circulating Antibodies Directed Against the S Protein of Severe Acute Respiratory Syndrome Coronavirus 2
Svenja Weiß, Jéromine Klingler, Catarina E. Hioe, Fatima Amanat, Ian L. Baine, Suzanne A. Arinsburg, Erna Milunka Kojic, Jonathan Stoever, Sean T. H. Liu, Denise Jurczyszak et al. · 2020 · The Journal of Infectious Diseases
Testing-on-a-probe biosensors reveal association of early SARS-CoV-2 total antibodies and surrogate neutralizing antibodies with mortality in COVID-19 patients
He S. Yang, Sabrina Racine‐Brzostek, Mohsen Karbaschi, Jim K. Yee, Alicia Dillard, Peter A.D. Steel, William T. Lee, Kathleen A. McDonough, Yuqing Qiu, Thomas J. Ketas et al. · 2021 · Biosensors and Bioelectronics
Identification of SARS-CoV-2–specific immune alterations in acutely ill patients
Rose‐Marie Rébillard, Marc Charabati, Camille Grasmuck, Abdelali Filali-Mouhim, Olivier Tastet, Nathalie Brassard, Audrey Daigneault, Lyne Bourbonnière, Sai Priya Anand, Renaud Balthazard et al. · 2021 · Journal of Clinical Investigation
kinetics of anti-SARS-CoV-2 antibodies over time. Results of 10 month follow up in over 300 seropositive Health Care Workers
José Felipe Varona, Rodrigo Madurga, Francisco J. Peñalver, Elena Abarca, Cristina Almirall, Marta Cruz, Enrique Ramos, Jose María Castellano-Vazquez · 2021 · European Journal of Internal Medicine
Recent advances in antibody‐based immunotherapy strategies for COVID‐19
Abdolreza Esmaeilzadeh, Samaneh Miri Rostami, Pegah Moharrami Yeganeh, Safa Tahmasebi, Majid Ahmadi · 2021 · Journal of Cellular Biochemistry